TRANSITIONAL CAREER DEVELOPMENT AWARD IN WOMEN’S HEALTH RESEARCH

Release Date:  January 14, 2000

RFA NUMBER:  OD-00-003

National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Heart, Lung, and Blood Institute 
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Office of Research on Women's Health
Foundation for the National Institutes of Health
Pfizer Women's Health, Pfizer Inc  
National Foundation for Biomedical Research

PURPOSE

The NIH Office of Research on Women's Health (ORWH) invites applications for the 
Transitional Career Development Award in Women's Health Research. This award is 
designed to support career development experiences leading to independence for 
clinical investigators interested in patient-oriented or population-based 
research related to women's health.  The career development program will provide 
an opportunity for investigators to develop solid clinical research skills 
during two years of study and research within the environment of the NIH 
Intramural Research Programs (IRP).  The award will also include a follow-on 
two-year period of salary and research support at an academic institution of the 
candidate's choice.  This period of extramural support will facilitate the 
transition to independence as a clinical researcher specializing in research 
issues related to women's health. 

Salary support for the intramural phase of the program will be provided by 
Pfizer Women's Health of Pfizer Inc through a grant to the Foundation for the 
National Institutes of Health (FNIH).   During this two-year period of career 
development, the candidate will engage in supervised clinical research and 
career development as a clinical or research fellow in the IRP of one of the NIH 
Institutes or Centers.  Research support for this segment of the award will be 
provided by the assigned NIH Institute or Center.  For the second phase of the 
award, research and salary support will be provided by ORWH in the form of an 
extramural career development award (K22) administered by the assigned NIH 
Institute or Center.   The career development award will be activated when the 
candidate has assumed a suitable, independent research position at an academic 
institution.  

Diseases of women of particular interest include therapeutic areas identified at 
the Beyond Hunt Valley Conference  (http://www4.od.nih.gov/orwh/orwhpubs.html) 
sponsored by the Office of Research on Women's Health.  This conference designed 
a research agenda for women's health in the 21st century.  Research projects 
should investigate the presentation, clinical course and/or management of any of 
the cardiovascular, cancer, metabolic, gastroenterologic, urologic, 
musculoskeletal, neuroendocrine, mental, infectious, or autoimmune diseases or 
any other medical conditions which occur with higher prevalence in women. 

HEALTHY PEOPLE 2000

The Public Health Service (PHS) is committed to achieving the health promotion 
and disease prevention objectives of "Healthy People 2000," a PHS-led national 
activity for setting priority areas.  This Request for Applications (RFA), 
Transitional Career Development Award in Women's Health Research, is related to 
one or more of the priority areas.  Potential applicants may obtain a copy of 
"Healthy People 2000" at http://odphp.osophs.dhhs.gov/pubs/hp2000.

ELIGIBILITY REQUIREMENTS

Individuals must have a health-professional doctoral degree or its equivalent 
and must be able to demonstrate the potential for highly productive patient-
oriented research. Individuals with the MD, MD-PhD, DO, DDS, Pharm.D-MS, 
Pharm.D-PhD, RN-PhD, or comparable clinical or combined clinical/research 
degrees are eligible to apply.   In most cases, applicants will have finished 
their clinical training and will have had some research experience in either a 
laboratory or clinical setting.  Candidates should possess aptitudes for 
independent, patient-oriented or population-based research (e.g. epidemiology, 
behavior, or disease prevention) and should be able to demonstrate a commitment 
to the study of diseases that occur in women.

Candidates must be able to demonstrate that after two years of supervised 
research and study at the NIH they will have the capacity to reach a level of 
competency necessary for independent research support.  Former or current 
principal investigators on National Institutes of Health (NIH) research project 
grants (P01, R01, R29), SBIR/STTR awards (R43, R44/R41, R42), center grants 
(P30, P50), subprojects of program project or center grants, career awards  
(K07,  K08, K23, K24), or the equivalent are not eligible.   Clinical fellows 
working in NIH intramural laboratories who meet the other eligibility 
requirements are eligible to apply.

During the intramural phase, the Transitional Career Awardee is expected to 
spend full time on research and research-related activities.  During the 
extramural phase, the Transitional Awardee must spend at least 75% of his/her 
full-time professional effort conducting research or engaged in research career 
development activities.  

Before submitting an application for the Transitional Career Award, the 
candidate must identify a researcher within the NIH IRP who will serve as the 
sponsor/mentor and will be committed to supervising the candidate and 
supervising her/his research and career development during the first phase of 
this award.  A list of potential sponsors within the IRP is available at 
http://grants.nih.gov/training/transitional_award.htm.  The sponsor must be an 
active investigator in the area of the proposed research and must provide 
evidence of successful mentoring of comparable clinical trainees.  Further, the 
sponsor must be able to provide the non-salary resources necessary for the 
proposed research and career development experience. 

All applicants are encouraged to contact the ORWH staff listed at the end of 
this announcement for information regarding their eligibility for this award 
prior to preparing an application.   

Racial/ethnic minority individuals, women, and persons with disabilities are 
encouraged to apply as Principal Investigators. Candidates must be U.S. citizens 
or non-citizen nationals, or must have been lawfully admitted for permanent 
residence and possess an Alien Registration Card (I-151 or I-152) or some other 
verification of legal admission as a permanent U.S. resident, at the time of the 
award.  Non-citizen nationals, although not U.S. citizens, are individuals who 
owe permanent allegiance to the U.S.  They are usually born in lands that are 
not states, but are under U.S. sovereignty, jurisdiction, or administration.  
Individuals on temporary or student visas are not eligible to apply.

MECHANISM OF SUPPORT

The Transitional Program will use the NIH Career Transition Award (K22) 
mechanism.  The planning, direction, and execution of the program will be the 
responsibility of the candidate and her/his mentor on behalf of NIH IRP in the 
first phase and the awardee institution on behalf of the candidate in the second 
phase.  

The total period of support for the Transitional Career Development Award is 
four years.  The program begins with two years of support for the Transitional 
Awardee's research training in the NIH intramural research environment.  Salary 
costs for this phase will be derived from a grant from Pfizer Women's Health to 
the Foundation for the National Institutes of Health.  Research costs will be 
provided by the NIH Institute which supports the sponsor's laboratory.   There 
is no extramural grant award associated with the intramural phase. If additional 
time is required for the intramural phase of the award period, all costs will be 
covered by the sponsoring NIH institute. The final two years of the Transitional 
Career Development Award will be supported by the ORWH through the awarding NIH 
Institute or Center.  The scholar will be funded through an extramural, non-
competing, NIH Career Transition Award (K22).  The award will be made in behalf 
of the candidate to the extramural institution in which the candidate secures a 
suitable research position.  During the extramural phase of the Career 
Transition Award, the Transitional Career Awardee is encouraged to apply for 
additional independent research support.  The Transitional Career Development 
Award is not renewable and not transferable to another investigator.  

During both the intramural and extramural phases of the award, candidates may be 
invited to attend Pfizer sponsored scientific conferences.  Pfizer will provide 
support to cover costs associated with travel to these conferences.  Candidates 
are required to acknowledge the source of support in any publication of findings 
that result from studies supported by this award (see the NIH Grants Policy 
Statement at http://grants.nih.gov/grants/policy/nihgps/part_ii_5.htm - 
rightsdata.

FUNDS AVAILABLE

A grant from Pfizer Women's Health to the Foundation for the National Institutes 
of Health will support the salary and fringe benefits for two Transitional 
Career Awardees during both years of career development within the NIH 
Intramural Programs.  The participating research groups within the NIH 
Intramural Programs will provide research support for the awardees during that 
period.  After the awardee is approved for transition to an extramural position, 
ORWH will provide continuing support for the two awardees for two additional 
years.  Additional awards may be funded at the discretion of the participating 
NIH Institutes and Centers.

RESEARCH OBJECTIVES

The Transitional Career Development Award will provide salary and research 
support for the training of outstanding, patient-oriented researchers in the 
area of women's health.  The program is uniquely designed to facilitate the 
transition of the candidate to an independent research career in the extramural 
research community.  This program will provide an opportunity to develop 
clinical research skills within the highly regarded NIH intramural research 
program and will then facilitate the transition to a position as an 
independently funded investigator at an extramural institution.  This is a novel 
opportunity for new exceptionally talented investigators to receive research 
training and establish an independent research program.  The Transitional 
Awardees Program will also benefit the NIH by providing a cadre of new, creative 
junior scientists who will expand the collaborative research opportunities 
within the NIH Intramural Programs.

ALLOWABLE COSTS

Intramural Phase:

A grant from Pfizer Women's Health will provide up to $100,000 per year to 
offset the intramural salary (or stipend) and fringe benefits for each 
successful candidate as well as the administrative fee for the Foundation for 
the National Institutes of Health.  Grants from Pfizer Women's Health will 
support two candidates during both years of career development within the IRP.   
During this phase of the award, the candidate will be classified as a research 
fellow or clinical fellow within the IRP. The salary or stipend provided to the 
Transitional Career Awardee will be commensurate with the level of training, 
experience, and clinical responsibilities of the candidate.   The salary and 
fringe benefits will be negotiated at the time of the award.  Laboratory 
equipment purchased for the candidate during the intramural phase is not 
transferable to the extramural institution. The sponsoring NIH laboratory will 
support the research expenses, training costs, equipment, and travel.

Extramural Phase:

Support for the extramural phase of both recipients of the Transitional Career 
Award will be provided by ORWH and may not exceed $175,000 in direct costs per 
year for two years.

1.  Salary:  At the extramural institution, the Transitional Career Awardee will 
be provided with salary support plus fringe benefits.  Salary requests should 
conform to the established, consistently applied policy of the institution for 
other staff members of equivalent qualifications, rank, and responsibilities.  
The total salary allowable must be based on a full-time, 12-month staff 
appointment for individuals of comparable rank and experience at that 
institution. In no case will the base salary provided by the award exceed the 
legislated maximum salary.  The institution may supplement the NIH contribution.  
However, supplementation may not be from Federal funds unless specifically 
authorized by the Federal program from which such funds are derived.  In no case 
may NIH funds be used for salary supplementation.  Institutional supplementation 
of salary must not require extra duties or responsibilities that would interfere 
with the purpose of this award.   During the extramural phase, the candidate 
must devote at least 75 percent effort to the proposed research and research 
career development program. 

2.  Research support: Award amounts above the salary costs can be used to 
support research expenses such as supplies, equipment, consultants, patient care 
costs, technical personnel, travel to research meetings or training, and 
statistical services.

3.  Ancillary Personnel Support: Salary for secretarial and administrative 
assistance is not allowed.

4. Facilities and Administrative Costs: F&A costs will be reimbursed at eight 
percent of modified total direct costs.

SPECIAL RESTRICTIONS

The Transitional Award is specifically intended to help develop scientists who 
will pursue careers in the extramural biomedical research community. The 
expectation is that the Transitional Career Awardee will move to a tenure-track 
or equivalent position in the extramural biomedical research community for the 
final two years.  However, the awardee is not explicitly precluded from applying 
for available tenure-track positions at the NIH.  If the awardee obtains an NIH 
tenure-track or other NIH position, the Transitional Award will be terminated.

INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS

It is the policy of the NIH that women and members of minority groups and their 
subpopulations must be included in all NIH supported biomedical and behavioral 
research projects involving human subjects, unless a clear and compelling 
rationale and justification is provided that inclusion is inappropriate with 
respect to the health of the subjects or the purpose of the research.  This 
policy implements Section 492B of the Public health Service Act, as amended by 
the NIH Revitalization Act of 1993, Public Law 103-43.

All investigators proposing research involving human subjects should read the 
"NIH Guidelines for Inclusion of Women and Minorities as Subjects in Clinical 
Research," which was published in the Federal Register of March 28, 1994 (FR 59 
14508-14513) and in the NIH Guide for Grants and Contracts, Vol. 23, No. 11, 
March 18, 1994, available on the web at: 
http://grants.nih.gov/grants/guide/notice-files/not94-100.html. 

INCLUSION OF CHILDREN AS PARTICIPANTS IN RESEARCH INVOLVING HUMAN SUBJECTS

It is the policy of NIH that children (i.e., individuals under the age of 21) 
must be included in all human subjects research, conducted or supported by the 
NIH, unless there are scientific and ethical reasons not to include them.  This 
policy applies to all initial (Type 1) applications submitted for receipt dates 
after October 1, 1998.

All investigators proposing research involving human subjects should read the 
"NIH Policy and Guidelines" on the Inclusion of Children as Participants in 
Research Involving Human Subjects that was published in the NIH Guide for Grants 
and Contracts, March 6, 1998, and is available at the following URL address: 
http://grants.nih.gov/grants/guide/notice-files/not98-024.html

Investigators also may obtain copies of these policies from the program staff 
listed under INQUIRIES.  Program staff may also provide additional relevant 
information concerning the policy.

APPLICATION PROCEDURES

Individuals interested in applying for the Transitional Award must identify a 
sponsor/mentor in NIH Intramural Research Programs (IRP).  A list of such 
opportunities is available on the NIH website at 
http://grants.nih.gov/training/transitional_award.htm.  The candidate must 
communicate directly with the identified sponsor whose research interest and 
training availability complements her/his own interests.  The application is 
prepared in consultation with identified sponsor.  A letter of support from the 
scientific director of the sponsoring laboratory or clinic must accompany the 
application.

Submission Procedures:

All candidates are strongly encouraged to contact the staff person in the ORWH 
and the relevant institute or center listed under INQUIRIES. Such contact should 
occur early in the planning phase of application preparation. Such contact will 
help ensure that applications are responsive to the goals and policies of the 
individual institute or center.

Applications are to be submitted on the grant application form PHS 398 (revision 
4/98) and should use the instructions in Section IV of the application kit.  The 
application will be accepted on or before March 20, 2000. Forms are available at 
most institutional offices of sponsored research and from the Division of 
Extramural Outreach and Information Resources, National Institutes of Health, 
6701 Rockledge Drive, MSC 7910, Bethesda, MD 20892-7910, Phone (301) 435-0714, 
FAX: (301) 480-0525, Email: GrantsInfo@nih.gov.  Forms are also available on the 
NIH Website at http://grants.nih.gov/grants/funding/phs398/phs398.html

To identify the application as a response to this Request for Applications, 
check "YES" on item 2 of page 1 of the application and enter RFA-OD-00-003  
"Transitional Career Development Award in Women's Health Research." The RFA 
label available in the PHS 398 (rev. 4/98) application form must be affixed to 
the bottom of the face page of the application.  Failure to use this label could 
result in delayed processing of the application such that it may not reach the 
review committee in time for review. 

The sample RFA label available at: 
http://grants.nih.gov/grants/funding/phs398/label-bk.pdf has been modified to 
allow for this change.  Please note this is in pdf format.

Submit a signed, typewritten original of the application with Checklist, and 
four signed photocopies, in one package to:

Center for Scientific Review
National Institutes of Health
6701 Rockledge Drive, Room 1040 - MSC 7710 
Bethesda, MD  20892-7710 or 
Bethesda, MD  20817-7710 (for express/courier service)

Submit a single photocopy of the signed original application to:

C. James Scheirer, Ph.D.
Deputy Director, DEA and Chief, Review Branch
National Heart, Lung, and Blood Institute, NIH
Rockledge Building II, Room 7216
6701 Rockledge Drive
Bethesda, MD  20892
Phone:   (301) 435-0266
Fax:     (301) 480-3541
E-mail:  js110j@nih.gov 

Applicants are also encouraged to send one photocopy of the application to Dr. 
Ruth Merkatz, Pfizer Women's Health, Pfizer Inc., 235 East 42nd Street, New 
York, NY 10017 for informational purposes. 

Supplemental Application Guidelines:

The initial application for the Transitional Career Development Award in Women's 
Health Research will not be processed through the individual's current 
institution.  Therefore, these supplemental guidelines should be followed:

Enter in item 6 (Dates of Proposed Period of Support) the combined years of 
support needed to complete the intramural and the extramural phases of the 
Transitional Awardees Program;

Leave items 9-14 on the face page blank;

Provide applicant's signature in item 15; 

A signature is not required for item 16;

Do not submit a Checklist Page;

The application must address the following issues:

Candidate

* Describe the candidate's commitment to a career in patient-oriented, women's 
health research;

* Establish the candidate's potential to develop into a successful independent 
investigator;

* Provide three sealed letters of recommendation addressing the candidate's 
potential for a productive and successful career in clinical research.  It is 
recommended that one letter should be from the most recent mentor or supervisor 
in either a postdoctoral research or clinical setting or from the applicant's 
thesis advisor.  These sealed letters must be attached to the face page of the 
original application.

Career Development Plan:

* Describe a career development plan incorporating the candidate's immediate and 
long-term career objectives and goals, explaining how the proposed program would 
contribute to their attainment;

* Describe a systematic plan to obtain the necessary research experience to 
launch an independent research career in the area of women's health research.  
Plans for continued scientific development for a research career may include the 
need for any courses, training in research techniques or methods, etc.;

* Describe plans to receive instruction in the responsible conduct of research.  
These plans must detail the proposed subject matter, format, frequency, and 
duration of instruction, as well as the amount and nature of senior staff 
participation.  No award will be made if an application lacks this component.  
Candidates and the sponsor may wish to explore the availability of the following 
courses offered by the IRP:  Introduction to the Principles and Practice of 
Clinical Research;  the clinical electives program course on bioethics; and the 
ethics training provided by each individual institute or center.  

Sponsor's Statement:

* Include information on the sponsor's research qualifications and previous 
experience as a postdoctoral mentor/supervisor;

* Describe the nature and extent of the sponsor's commitment and supervision 
that will occur during the intramural phase of this program;

* Describe the elements of research training planned for the candidate, 
including any formal courses for the candidate and demonstrate how these will 
promote the candidate's scientific independence.

Intramural Environment and Institutional Commitment:

* The sponsor should document a strong, well-established research program 
related to the candidate's area of interest, including an environment with staff 
capable of productive collaboration with the candidate;

* Provide a statement from the Scientific Director of the NIH Intramural 
Research Program in support of the proposed career development experience and 
committing resources to foster the candidate's development into a productive, 
independent investigator if an award is made.

Research Plan:

* Describe the research plan as outlined in the PHS 398 application kit, 
"Research Career Award section".  Include information on the hypothesis and 
specific aims, background, significance and rationale, preliminary studies and 
any results, and research design and methods.  The candidate should consult with 
the sponsor regarding the development of the research proposal;

* Describe research plans that are sufficient to justify two years of support in 
the intramural laboratory;

* Provide future research directions for the extramural phase, i.e., what are 
the broad research goals and potential avenues of research that would be 
stimulated by the  specific research project;

* Relate the research plan to the candidate's career goals and career 
development plan.

Budget:

* Provide an estimated budget for the intramural phase of the award using the 
instructions in the PHS 398 application kit.  The final budget will be 
negotiated when the candidate accepts the award.  Award amounts provided will 
remain within the allowable costs specified above.  Budget estimates for the 
extramural phase of the award do not need to be supplied at the time of 
application.  

Application Receipt Date:      March 20, 2000
Peer Review:                   June, 2000
Council Review:                September, 2000
Earliest Possible Start Date:  September, 2000

REVIEW CONSIDERATIONS

Upon receipt, applications will be reviewed by the CSR and other extramural 
staff for completeness and for responsiveness to this RFA.  Applications that 
are incomplete and/or unresponsive will be returned to the applicant without 
further consideration.

All applications considered to be complete and responsive will be evaluated for 
scientific and technical merit in accordance with the review criteria stated 
below by an initial peer review group (IRG) convened by the Scientific Review 
Branch, Division of Extramural Activities, National Heart, Lung, and Blood 
Institute.  As part of the initial merit review, applications will receive a 
priority score and a written critique.  In addition, applications will receive a 
second level of review by the advisory council or board of the sponsoring NIH 
Institute.

Review Criteria

The peer review criteria for applications submitted in response to this RFA are:

Candidate

* Potential to develop into a productive, independent scientist;

* Commitment to a career in patient-oriented or population-based woman's health 
research;

* Quality and breadth of prior scientific training and experience including, 
where appropriate, a record of previous research support and publications.

Career Development Plan

* Likelihood that the career development plan will contribute substantially to 
the scientific development of the candidate, considering the candidate's goals 
and prior experience;

* Consistency of the career development plan for both the intramural and 
extramural phases and the stated career goals of the candidate;

* Appropriateness of the plan to obtain training in the responsible conduct of 
research.

Sponsor

* Appropriateness of Intramural sponsor's research qualifications in the 
scientific area of this application and the sponsor's history of research 
productivity and support;

* The level of commitment of the sponsor during the intramural phase of the 
award to career guidance and the development of the candidate's skills and 
knowledge;

* Previous experience and success in fostering the development of young 
researchers; 

Research Plan

* Consistency of the research plan and the candidate's level of research 
development and training;

* Appropriateness of the research plan as a vehicle for developing the needed 
research skills;

* Scientific and technical merit of the research question, design and 
methodology.

* Relationship of the broad research goals and scientific directions for the 
extramural phase to the specific research project identified in the intramural 
phase;

Institutional Commitment and Environment

* Appropriateness of environment and the resources committed by the IRP to the 
candidate's research and career development.

Budget

* Justification of budget request for the intramural phase of the award in 
relation to needs of the research project and training activities proposed.

AWARD CRITERIA

The institute or center will notify the applicant of the board or council's 
action shortly after its meeting.  Funding decisions will be made based on the 
recommendations of the initial review group and council/board, the need for 
research personnel in specific program areas, and the availability of funds.

The progress of the candidate's research and career development will be 
monitored annually during the intramural phase of this award by a committee 
composed of representatives of Pfizer Women's Health and scientists from the 
relevant intramural and extramural NIH programs.  The results of these formal 
reviews will be presented in writing to the Transitional Career Awardee, the 
sponsor within the IRP, and to extramural program staff within the NIH 
sponsoring/awarding Institute.  

Prior to activation of the extramural phase of the program, the Transitional 
Career Awardee must obtain a position as an independent researcher at an 
eligible, sponsoring extramural institution. The extramural institution must 
demonstrate a commitment to the Transitional Career Awardee by providing 
protected research time and sufficient space and resources needed to perform the 
proposed research. The candidate will describe plans for the research and career 
development at the extramural institution and will request a change of 
institution by submitting an abbreviated application using the career 
development sections of form PHS 398.  This application must be received by the 
extramural program official at the sponsoring/ awarding NIH Institute at least 
four months prior to the beginning of the expected start date of the extramural 
phase.  The information in this application along with the candidate's progress 
reports from the intramural phase will be used to determine the suitability of 
an extramural award. 

Disapproval of the extramural phase of the award may result in a terminal 
(third) year of NIH intramural support if approved by the NIH 
sponsoring/awarding institute or center.  In cases of disapproval, no transition 
funding to the extramural environment will be provided.  Approval of the 
transition to the extramural phase of the award can be made at any time prior to 
the end of the second year of intramural support.  However, the maximum duration 
of the extramural phase will be two years and any remaining portion of the 
intramural phase will not be carried over into the extramural phase.

INQUIRES

Inquires are encouraged concerning this PA, especially during the planning phase 
of the application.  The opportunity to clarify any issues or address questions 
from potential applicants is welcome.

Address inquiries regarding programmatic issues to:

National Institute on Aging 
Dr. Robin A. Barr 
Office of Extramural Affairs 
7201 Wisconsin Avenue, Room 2C218, MSC 9205 
Bethesda, MD  20892-9205 
Telephone:  (301) 496-9322 
FAX:  (301) 402-2945 
Email:  rb42h@nih.gov

National Institute of Allergy and Infectious Diseases 
Dr. Milton Hernandez 
Office of Scientific Training and Manpower Development 
Solar Building, Room 3C21 
Bethesda, MD  20892 
Telephone:  (301) 496-7291 
FAX:  (301) 402-0369 
Email:  mh35c@nih.gov

National Institute on Arthritis and Musculoskeletal and Skin Diseases 
Richard W. Lymn, Ph.D.
Research Training Officer
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Building 45, Room 5AS-49E
Bethesda, MD  20892-6500
Telephone:  (301) 594-5128
FAX:  (301) 480-4543
Email:  richard_w_lymn@nih.gov

National Cancer Institute 
Dr. Lester S. Gorelic or Dr. Andrew Vargosko 
National Cancer Institute
Office of the Deputy Director for Extramural Sciences
Office of Centers, Training and Resources 
Executive Plaza North, Room 520, MSC 7390 
Bethesda, MD  20892-7390 
Telephone:  (301) 496-8580 
FAX:  (301) 402-4472 
Email: lg2h@nih.gov or av8b@nih.gov

National Institute of Child Health and Human Development 
Donna L. Vogel, M.D., Ph.D.
Reproductive Sciences Branch
Center for Population Research
Building 6100,  Room 8B01 MSC 7510
Bethesda, MD 20892-7510
Telephone: 301-496-6515
FAX: 301-496-0962
Email: dv1h@nih.gov

National Institute on Dental and Craniofacial Research
James A. Lipton, Ph.D.
Special Assistant for Training and Career Development 
Natcher Building, Room 4AN.18J 
Bethesda, MD  20892-6402
Telephone:  (301) 594-2618 
FAX:  (301) 480-8319 
Email:   liptonj@de45.nidcr.nih.gov 

National Institute on Drug Abuse
Cora Lee Wetherington, Ph.D.
Women and Gender Research Coordinator
6001 Executive Boulevard, Room 4282, MSC 9555
Bethesda, MD 20892-9555
Telephone: 301-443-1263
FAX: 301-594-6043
Email:  wetherington@nih.gov


National Institute of Environmental Health Sciences 
Dr. Carol Shreffler
Division of Extramural Research and Training
P. O. Box 12233  MD EC-23
Research Triangle Park, NC  27709
Telephone:  (919) 541-1445
FAX:  (919) 541-5064
Email:  shreffl1@niehs.nih.gov

National Heart, Lung, and Blood Institute 
Beth Schucker, M.A.
National Heart, Lung, and Blood Institute
Two Rockledge Center, Room 9206
6701 Rockledge Drive, MSC 7940
Bethesda, Maryland 20892-7940
Phone: (301) 435-0535
FAX: (301) 480-1454
E-mail: SchuckeB@nih.gov

National Institute of Mental Health 
Mary C. Blehar, Ph.D.
Chief, Women's Mental Health Program
National Institute of Mental Health
6001 Executive Boulevard 
Room 8125, MSC 9569
Bethesda, Maryland 20892-9659
Phone:  (301) 443-2847
FAX:  (301) 443-8552
E-mail:  BleharM@nih.gov

National Institute of Neurological Disorders and Stroke 
Joseph S. Drage, M.D.
Training and Special Programs Officer, OD, NINDS
Neuroscience Center Room 3309
Bethesda, MD 20892-9531
Telephone: (301) 496-4188
FAX: 301-402-4370
Email: jd66x@nih.gov

National Institute of Nursing Research 
Nell Armstrong, PhD, RN 
Program Director
Division of Extramural Activities
NINR/NIH
Bethesda, MD 20892
Telephone:  301-594-5973
FAX:  301-480-8260
Email:    nell_armstrong@nih.gov

Office of Research on Women's Health
Joyce Rudick
Director, Programs and Management
Office of Research on Women's Health
Building 1, Room 201
9000 Rockville Pike
Bethesda, MD 20892-0161
Phone: 301 402-1770
Fax: 301 402-1798
email: rudickj@od.nih.gov 

Foundation for the National Institutes of Health
Theodore R. Colburn, Ph.D.
Scientific Director
Foundation for the National Institutes of Health, Inc.
1 Cloister Court, Suite 152
Bethesda, MD 20814-1460
Phone: 301-435-4686
Fax: 301-480-2752
email: tc7v@nih.gov

AUTHORITY AND REGULATIONS

This program is described in the Catalog of Federal Domestic Assistance No. 
93.867.  Awards are made under the authority of Section 301, 405, 486, and 499 
of the PHS Act as amended (Public Law 78-410, as amended, 42 USC 241, 284, 287d, 
and 290b).  The Code of Federal Regulations, Title 42 Parts 52 and 63, and Title 
45  Part 74, are applicable to this program.  This program is not subject to the 
intergovernmental review requirements of Executive Order 12372 or Health Systems 
Agency review. The Foundation for the National Institutes of Health, Inc. is an 
independent non-profit 501(c)(3) corporation established by Congress to support 
the mission of NIH.  The Foundation's authorizing legislation permits the 
solicitation, receipt and management of grants from outside organizations to 
support NIH programs. 

The PHS strongly encourages all grant recipients to provide a smoke-free 
workplace and promote the non-use of tobacco products. In addition, Public Law 
103-227, The Pro-Children Act of 1994, prohibits smoking in certain facilities 
(or, in some cases, any portion of a facility) in which regular or routine 
education, library, day care, health care, or early childhood development 
services are provided for children.  This is consistent with the PHS mission to 
protect and advance the physical and mental health of the American people.

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files.